Also
- Share via
Biogen Idec Inc. said it would buy closely held Conforma Therapeutics Corp. of San Diego for as much as $250 million. Conforma would bring Biogen two experimental cancer compounds in the earliest stage of human tests. The deal is expected to be completed in the second quarter.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
